IdentificationGeneric Name(2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphateDrugBank Accession NumberDB04112BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


Download MOLSDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate (DB04112)× CloseWeightAverage: 539.749 Monoisotopic: 539.340945667 Chemical FormulaC26H54NO6PSSynonyms1-Octadecyl-2-acetamido-2-deoxy-SN-glycerol-3-phosphoethylmethyl sulfidePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUPhospholipase A2, membrane associatedNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as phosphoethanolamines. These are compounds containing a phosphate linked to the second carbon of an ethanolamine.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassOrganic phosphoric acids and derivativesSub ClassPhosphate estersDirect ParentPhosphoethanolaminesAlternative ParentsDialkyl phosphates / Acetamides / Secondary carboxylic acid amides / Sulfenyl compounds / Dialkylthioethers / Dialkyl ethers / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compoundsSubstituentsAcetamide / Aliphatic acyclic compound / Alkyl phosphate / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Dialkyl ether / Dialkyl phosphate / Dialkylthioether / EtherMolecular FrameworkAliphatic acyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyZULTVWFLRZJENJ-AREMUKBSSA-NInChIInChI=1S/C26H54NO6PS/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-31-23-26(27-25(2)28)24-33-34(29,30)32-21-22-35-3/h26H,4-24H2,1-3H3,(H,27,28)(H,29,30)/t26-/m1/s1IUPAC Name[(2R)-2-acetamido-3-(octadecyloxy)propoxy][2-(methylsulfanyl)ethoxy]phosphinic acidSMILES[H]N([C@H](COCCCCCCCCCCCCCCCCCC)COP(O)(=O)OCCSC)C(C)=OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5288635PubChem Substance46506883ChemSpider4450758ZINCZINC000014881051PDBe LigandINBPDB Entries1aypClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.000349 mg/mLALOGPSlogP6.11ALOGPSlogP7.11ChemaxonlogS-6.2ALOGPSpKa (Strongest Acidic)1.92ChemaxonpKa (Strongest Basic)-1.6ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area94.09 Å2ChemaxonRotatable Bond Count27ChemaxonRefractivity147.14 m3·mol-1ChemaxonPolarizability65.12 Å3ChemaxonNumber of Rings0ChemaxonBioavailability0ChemaxonRule of FiveNoChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.7114Blood Brain Barrier+0.9087Caco-2 permeable-0.6319P-glycoprotein substrateSubstrate0.5192P-glycoprotein inhibitor INon-inhibitor0.6232P-glycoprotein inhibitor IINon-inhibitor0.8781Renal organic cation transporterNon-inhibitor0.9514CYP450 2C9 substrateNon-substrate0.8357CYP450 2D6 substrateNon-substrate0.8093CYP450 3A4 substrateNon-substrate0.5CYP450 1A2 substrateNon-inhibitor0.827CYP450 2C9 inhibitorNon-inhibitor0.8166CYP450 2D6 inhibitorNon-inhibitor0.9045CYP450 2C19 inhibitorNon-inhibitor0.7071CYP450 3A4 inhibitorNon-inhibitor0.7477CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9577Ames testNon AMES toxic0.6566CarcinogenicityNon-carcinogens0.7883BiodegradationNot ready biodegradable0.9207Rat acute toxicity2.5871 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9256hERG inhibition (predictor II)Non-inhibitor0.7726  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Phospholipase A2, membrane associatedKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionPhospholipid bindingSpecific FunctionThought to participate in the regulation of the phospholipid metabolism in biomembranes including eicosanoid biosynthesis. Catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-ph...Gene NamePLA2G2AUniprot IDP14555Uniprot NamePhospholipase A2, membrane associatedMolecular Weight16082.525 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at July 11, 2020 03:42 